Magnesium, too, will stay in my armoury, simply because I feel better taking it than not
Characteristics of normal urinary changes during Saxenda treatment include: Gradual increase in frequency over the first few weeks Clear or pale yellow urine indicating good hydration No pain, burning, or discomfort during urination Reasonable sleep patterns (though some nocturia is normal, especially in older adults) Correlation with increased water intake or dietary changes Conversely, concerning symptoms that warrant medical evaluation include: Excessive thirst (polydipsia) accompanied by very frequent urination (polyuria)potentially indicating hyperglycaemia or diabetes (consider checking blood glucose and urine ketones if available) Painful urination (dysuria), urgency, or sensation of incomplete bladder emptyingsuggesting urinary tract infection Blood in the urine (haematuria), even if microscopic or intermittent Nocturia (waking multiple times nightly to urinate) that significantly disrupts sleep Urinary incontinence or sudden inability to control bladder function Dark, concentrated urine despite adequate fluid intakepossibly indicating dehydration Fever with flank pain or rigorssuggesting possible kidney infection (pyelonephritis) Patients should also monitor for signs of dehydration , which can occur if increased urination is not matched by adequate fluid replacement
Gong J, Harris K, Lipnicki DM, et al
For the fMRI group of WT mice, we used data from 11 WT mice recorded with an identical protocol from a previous, unpublished study
The effect of maternal GLP-1 agonist exposure on fetal outcomes in the real world is still being determined
However, our lipotropic injections do not contain the stimulant ephedrine, which can cause issues for some patients
